-
PTC CARDINALS (STOP STUDY and ALS DEVOLEPMENT)
PTC Therapeutics CARDINALS trial A randomised double-blind, placebo-controlled parallel study to assess the efficacy, safety, tolerance, pharmacokinetics and biomarker effects of PTC-857 in adult patients with Amyotrophic Lateral Sclerosis. This… More >>
-
Corcept Therapeutics DAZALS (ACTIVE)
A multicentric, randomized, double blind, placebo controlled phase 2-study to evaluate the efficacy and safety of CORT113176 (dazucorilant) in patients with Amyotrophic Lateral Sclerosis (DAZALS). This phase II study is… More >>
-
Wave FOCUS-C9 trial (STOP STUDY and ALS DEVELOPMENT)
FOCUS-C9 Clinical Trial Advances; Complete Data Due 1st Half 2023 The ongoing trial is investigating effects of Wave Life Sciences’ WVE-004 The ongoing clinical trial of Wave Life Sciences’ WVE-004… More >>
